Linear Source Registry for Prostate Cancer
NCT02516709 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2023-09-08
Summary
Ongoing follow up for subjects implanted with the Linear Source String for prostate cancer.
Conditions
Interventions
- RADIATION
-
Linear LDR Source
The Linear LDR source is a permanent interstitial brachytherapy implant containing palladium-103 sources for the treatment of prostate cancer.
Sponsors & Collaborators
-
CivaTech Oncology
lead INDUSTRY
Principal Investigators
-
Kristy Perez, PhD · CivaTech Oncology
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-06-30
- Primary Completion
- 2023-06-30
- Completion
- 2023-06-30
Countries
- United States
Study Locations
More Related Trials
-
Detection and Localization of Carcinoma Using High Resolution Transrectal Imaging - Proof of Concept Study
NCT02786459 ·Status: COMPLETED ·Phase: NA
-
PRO-MR-RT Systematic Patient-reported Outcomes to Pelvic Online MRgRT
NCT05615909 ·Status: COMPLETED
-
Deformable Registration of Multi-parametric MRI to Intra-operative Transrectal Ultrasound for Prostate Brachytherapy
NCT02790216 ·Status: UNKNOWN
-
Long-Term Outcomes of Alternative Brachytherapy Techniques for Early Prostate Cancer
NCT00681694 ·Status: UNKNOWN
-
Optimizing Veteran-Centered Prostate Cancer Survivorship Care
NCT01900561 ·Status: COMPLETED ·Phase: NA
-
Magnetic Resonance Imaging and Spectroscopy of the Prostate
NCT00590993 ·Status: COMPLETED
-
Circulating Tumor Cells in High-Risk Prostate Cancer Treated With High-dose Radiotherapy and Hormone Therapy
NCT01800058 ·Status: COMPLETED
-
Safety Study of MRI-guided Transurethral Ultrasound Ablation of Prostate Tissue to Treat Localized Prostate Cancer
NCT01686958 ·Status: COMPLETED ·Phase: NA
-
Intrinsic Validity of Molecular Marker(s) Detection on Tissular Tumoral DNA to Predict the Efficacy of 177Lutetium-PSMA-617 (Lu-PSMA) Treatment for Castration-resistant Metastatic Prostate Cancer
NCT06600802 ·Status: RECRUITING ·Phase: NA
-
Multi-omic Approach to Study HDR Brachytherapy for Favorable Risk and Low Tier Intermediate Risk Prostate Cancer
NCT06200974 ·Status: RECRUITING
-
Using MRI to Identify Areas to Receive Lower Doses of Radiation Treatment in Men With Prostate Cancerdose Mapping to Preserve Quality of Life
NCT06171269 ·Status: RECRUITING ·Phase: NA
-
Identifying Prostate Brachytherapy Seeds Using MRI
NCT01878058 ·Status: COMPLETED ·Phase: NA
-
Focal Laser Ablation of Low to Intermediate Prostate Cancer Tumors
NCT02600156 ·Status: COMPLETED ·Phase: NA
-
Using Magnetic Resonance Imaging (MRI) to Guide Differential-Dose Prostate Brachytherapy
NCT01913197 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Registry of Irreversible Electroporation for the Ablation of Prostate Cancer With Use of Nanoknife Device
NCT02255890 ·Status: UNKNOWN
-
C-arm Cone-beam CT in Prostate Brachytherapy
NCT02322931 ·Status: UNKNOWN ·Phase: NA
-
Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate Cancer
NCT04692675 ·Status: RECRUITING ·Phase: NA
-
CyberKnife Radiosurgery For Low & Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy Dosimetry
NCT00643617 ·Status: COMPLETED ·Phase: NA
-
MRI Screening in Men at High Risk of Developing Prostate Cancer
NCT05608694 ·Status: RECRUITING ·Phase: NA
-
PSMA-PET/MRI Low- and Intermediate-Risk Prostate Cancer
NCT04243941 ·Status: WITHDRAWN ·Phase: PHASE2
-
Long-Term Prospective Registry in Prostate Cancer Patients From Diverse Urology Practice Settings Following Prolaris® Testing
NCT04404894 ·Status: ACTIVE_NOT_RECRUITING
-
Study of Hypofractionated Proton Beam Radiation Therapy for Prostate Cancer
NCT00831623 ·Status: COMPLETED ·Phase: NA
-
High-Dose-Rate Brachytherapy
NCT00913939 ·Status: RECRUITING ·Phase: NA
-
LDR vs. HDR Brachytherapy for Prostate Cancer
NCT03426748 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Defining the Extent and Grade of Prostate Cancer Using Dynamic Contrast Enhanced Diffusion Weighted and BOLD MRI
NCT00242112 ·Status: COMPLETED ·Phase: NA